Yokohama, Japan

Seiji Shibahara


Average Co-Inventor Count = 6.7

ph-index = 7

Forward Citations = 177(Granted Patents)


Location History:

  • Tsukushino, Machida-shi, Tokyo, JP (1985)
  • Machida, JP (1984 - 1997)
  • Kanagawa, JP (1994 - 1997)
  • Kanagawa-ken, JP (1997)
  • Yokohama, JP (1989 - 1998)
  • Tokyo, JP (1981 - 2012)

Company Filing History:


Years Active: 1981-2012

Loading Chart...
Areas of Expertise:
Antibiotics
Cephalosporin Derivatives
Macrolide Derivatives
Benzoxazole Derivatives
Dibekacin Derivatives
Oxamic Acid Compounds
Thiazole Derivatives
Pyrrolidin-2-ylcarbonyl Compounds
Actinonin Derivatives
Azole Derivatives
Cephem Compounds
Antibacterial Agents
44 patents (USPTO):Explore Patents

Title: Innovations by Seiji Shibahara: A Pioneer in Antibiotics

Introduction

Seiji Shibahara, based in Yokohama, Japan, is an accomplished inventor with a remarkable portfolio of 44 patents. His work primarily focuses on developing novel antibiotic substances that address critical health challenges posed by bacterial infections, particularly those caused by Gram-positive bacteria.

Latest Patents

Among Shibahara's latest innovations are a series of antibiotics known as bispolides A1, A2, A3, B1, B2a, B2b, and B3. These antibiotics have been derived from a unique microbial strain isolated from soil, designated as strain A 34030. This strain, deposited under the access number FERM BP-10505 in accordance with the Budapest Treaty, has led to the discovery of seven distinct antibiotic substances. Each of these bispolides exhibits significant antibacterial activity against various bacteria and is particularly effective against antibiotic-resistant strains of Gram-positive bacteria. This innovation opens new therapeutic options for treating bacterial infections in both humans and animals.

Career Highlights

Throughout his career, Shibahara has worked with notable organizations, including Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His contributions have greatly advanced the field of pharmaceuticals, particularly in the development of antibiotic compounds that offer new solutions for combating resistant bacterial strains.

Collaborations

Seiji Shibahara has collaborated with distinguished colleagues such as Tsuneo Okonogi and Shinichi Kondo. These partnerships have enriched his research endeavors, leading to the successful development of innovative antibiotic substances that reflect the collaborative spirit of scientific exploration.

Conclusion

Seiji Shibahara stands out as a significant figure in the field of antibiotic research and development. His extensive list of patents underlines his commitment to innovation and his contributions to combating bacterial infections through novel antibiotic substances. His ongoing work continues to inspire future advancements in medical treatments and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…